Aims: Glycoprotein IIb/IIIa blocking agents seem to improve percutaneous coronary intervention (PCI) results in patients with ST-elevation myocardial infarction (STEMI). We aimed to compare
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com